PLANO, TX, March 10, 2017 /CNW/ - Alternate Health Corp. (CSE:AHG) (OTC:AHGIF) (the "Company"), Alternate Health announced today that it has listed its shares for trading on the OTC bulletin board under the ticker symbol AHGIF, joining other top medical cannabis companies like Canopy Growth Corporation (TSX:WEED.TO) and GW Pharmaceuticals (NASDAQ: GWPH) in the largest cannabis market in the world.

Yesterday, Alternate Health also announced the closing of its recent capitalization of $7,569.055, less a finder's fee of $259,330.50. The company issued 2,238,940 common shares at a price of $3.25 Canadian ($2.50 US). The company currently has an on-hand cash position of over $12 million, all common shares issued under this private placement have a 4-month hold period in accordance with regulators and expiring July 7, 2017. Finders fees will be paid as permitted by the CSE policies and applicable securities laws.

"We are very excited to introduce the Alternate Health companies to American shareholders, as we have tremendous business interests in the US through our labs and technologies, as well as a growing suite of patented pharmaceutical delivery systems for medical cannabis," said Bryan Korba, CEO of Alternate Health Corp. "Our laboratory business is very profitable and that serves to fund development of our software and technology, as well as conducting research and obtaining the approvals necessary for our patented delivery systems."

Through ongoing research and testing, Alternate Health will demonstrate its market leading position in this emerging sector of Healthcare.

About Alternate Health Corp.

Alternate Health Corp (http://www.alternatehealth.ca) is a diversified healthcare company that uses its expertise in technology to revolutionize patient care and service delivery in both traditional and complementary medical fields. With investments in research, education and cutting edge technology, Alternate Health is a leader in software applications and processing systems for the medical industry using proprietary technology platforms. Through its subsidiaries, Alternate Health offers services ranging from medical practice and controlled substance management software to blood analysis and toxicology labs, to clinical research and continuing education programs. Alternate Health's goal is to continue to lead the medical industry with data-driven results in patient care and product development.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward looking statements.

SOURCE Alternate Health Corp.

For further information: Jim Griffiths, Director of Investor Relations, 416-607-5757